U.S. Biotech Stock News

In recent days, S2 Resources completed the sale of its Fosterville exploration licence EL007795 to a 100% owned Agnico Eagle Mines subsidiary, with Agnico Eagle paying A$17,000,000 through Southern Star Exploration as it continues expanding its international gold portfolio across stable mining jurisdictions. At the same time, Agnico Eagle’s momentum-focused Zacks Rank #1 rating, supported by upward earnings estimate revisions and recent outperformance in the gold mining industry, has drawn...

In December 2025, Labaton Keller Sucharow LLP announced that StoneCo and lead plaintiff Indiana Public Retirement System reached a proposed US$26,750,000 settlement to resolve securities litigation covering investors who bought StoneCo shares between May 27, 2020 and November 16, 2021, with a court hearing set for February 27, 2026. The proposed settlement, which StoneCo accepts without admitting wrongdoing, could reduce legal uncertainty for investors while formalizing the scope of past...

In December 2025, Perfect Corp. announced it will showcase a new generation of AI beauty agents and a modular, consumption-based API suite at CES 2026, aimed at powering personalized, cross-channel experiences for brands of all sizes. The move signals a push to become an infrastructure provider for beauty and retail AI, shifting from standalone apps toward developer-first tools that can embed Perfect’s technology across e-commerce, mobile, and in-store journeys. We’ll now examine how...

Arcus Biosciences (RCUS) just shook up its pipeline strategy by scrapping the high profile Phase 3 STAR-221 gastric cancer trial after an interim look showed no survival benefit for its domvanalimab combo. See our latest analysis for Arcus Biosciences. Despite the headline setback in gastric cancer, investors seem to be looking through the domvanalimab news to Arcus Biosciences longer term pipeline potential. The share price is $23.22, with a powerful 90 day share price return of 87.41...

Earlier this month, CBRE announced a series of leadership changes effective January 1, 2026, promoting Andy Glanzman to CEO of Real Estate Investments, elevating Adam Nims to CEO of Trammell Crow Company, and appointing Adam Saphier as Global COO of Advisory Services, while Danny Queenan moves into an Executive Group President role. These promotions consolidate oversight of CBRE’s development and investment management arms under Glanzman and tighten global operational control in Advisory...

On December 19, 2025, Okta expanded its Board of Directors from 10 to 11 members, appointing industry veterans Rob Bernshteyn and Paul Sagan as independent directors while confirming the earlier resignation of Mary Agnes (Maggie) Wilderotter for personal reasons unrelated to the company. By adding leaders with long experience in SaaS, cybersecurity and enterprise software governance, Okta is reinforcing its push to be a neutral identity partner in an era where AI-driven security and...

Earlier this month, Cohen & Steers, Inc. expanded its actively managed ETF lineup by launching the Cohen & Steers Infrastructure Opportunities Active ETF (CSIO) and the Cohen & Steers Short Duration Preferred and Income Active ETF (CSSD), which began trading on NYSE Arca. By adding infrastructure and short-duration preferred income ETFs to its existing real assets platform, the firm is signaling a stronger push to package its real estate and alternative income expertise in lower-cost,...

In December 2025, Darling Ingredients announced a definitive agreement with Tessenderlo Group to combine their Rousselot and PB Leiner collagen and gelatin businesses into a new joint company with about US$1.50 billion in annual revenue and 200,000 metric tons of capacity across 22 global facilities, while also expanding 2025 sales of renewable fuel production tax credits from its Diamond Green Diesel joint venture to US$235 million. This combination of a large-scale, no-cash-required...

Ocugen, Inc. recently presented at the Oppenheimer Movers in Rare Disease Summit in New York City on 11 December 2025, with Co-Founder, CEO and Chairman Shankar Musunuri highlighting the company’s rare disease focus. This appearance gives Ocugen a platform to spotlight its gene and cell therapy pipeline to an audience focused on rare diseases, potentially shaping expectations around its development path and partnering opportunities. We’ll now examine how this rare disease summit appearance...

Short term stock performance and recent moves GitLab (GTLB) has quietly slipped over the past 3 months, with the stock down around 21% and roughly 32% lower year to date, even as revenue continues to grow. See our latest analysis for GitLab. That slide has left GitLab with a roughly 32 percent year to date share price return in the red and a 1 year total shareholder return of about negative 36 percent. This suggests momentum has cooled as investors reassess the balance between strong growth...

Darden Restaurants (DRI) just packed several investor friendly updates into one day, pairing a quarterly dividend declaration and buyback progress with mixed second quarter earnings and fresh 2026 guidance. See our latest analysis for Darden Restaurants. The latest earnings beat on sales, softer margin commentary and the newly raised 2026 growth outlook are landing against a share price of $189.26, with solid upward momentum reflected in an 8.3 percent 1 month share price return and longer...

Northern Oil and Gas, Inc. recently completed a joint acquisition of a 49% stake in Ohio Utica Shale assets for US$588 million in cash as part of a broader US$1.20 billion package that also includes upstream assets and midstream infrastructure. At the same time, the company has expanded its natural gas and oil hedging program through 2026 and beyond, including substantial coverage of Ohio-Utica production, aiming to steady cash flows and underpin its capital program amid commodity price...

Austin-based Beck Capital Management disclosed that it cut its stake in Golar LNG during the third quarter, selling 117,966 shares, even as the company highlighted long-term FLNG contracts and maintained both dividends and a new US$150 million share buyback plan. The move reflects portfolio risk management within a tech-heavy fund, while Golar LNG’s roughly US$17 billion adjusted EBITDA backlog suggests management confidence in long-term cash flow visibility. Next, we’ll explore how Beck...

In December 2025, BlackLine, Inc. expanded its global cloud footprint by launching a locally hosted region in Saudi Arabia on Google Cloud Platform, enabling organizations to use its AI-enabled financial operations platform while meeting the Kingdom’s NCA Essential Cybersecurity Controls and Cloud Cyber Security Controls requirements. This move gives BlackLine a locally compliant, low-latency presence in a fast-modernizing market, potentially deepening its role in Saudi Arabia’s finance...

Recently, Jim Cramer praised M&T Bank as a very well-run and attractively priced institution, while Ariel Investments emphasized its regional strengths, measured acquisitions, and proactive efforts to reduce commercial real estate risk. Both commentators pointed to M&T’s ability to pair disciplined risk reduction with potential benefits from private credit partnerships, highlighting how its regional focus could underpin resilience despite near-term credit pressures. We’ll now explore how...

In December 2025, Virgin Galactic announced a Cooperative Research and Development Agreement with Lawrence Livermore National Laboratory to evaluate using LLNL sensor systems on its future launch vehicles and HALE-Heavy aircraft for advanced image-capture capabilities. This collaboration links Virgin Galactic with a key U.S. Department of Energy lab, potentially opening doors to government-backed research work and specialized data-gathering missions. We’ll now examine how this LLNL sensor...

Helmerich & Payne announced that long-time CEO John Lindsay will retire as CEO and director after the March 4, 2026 annual meeting, with current President Raymond John “Trey” Adams set to assume the CEO role and Lindsay staying on as senior advisor through December 2026 to aid the transition. Alongside this planned leadership handover, the company reaffirmed its shareholder focus with a US$0.25 quarterly dividend declaration and outlined disciplined capital spending and debt repayment goals...

Earlier this month, Triumph Financial announced that BlueGrace Logistics joined the Triumph Network, integrating Triumph's TFX payment platform, QuickPay, and related solutions to automate back-office processes, improve carrier visibility, and offer more flexible, transparent payment options. This move highlights how Triumph's payment technology is becoming further embedded in the freight ecosystem, potentially deepening its role in carrier and broker relationships across the logistics...

HA Sustainable Infrastructure Capital, Inc. recently amended its unsecured CarbonCount®-based revolving credit facility, lifting available commitments by US$100 million to US$1.65 billion and extending its access to flexible funding, while long-serving Executive Vice President and Chief Legal Officer Steven L. Chuslo agreed to shift into a strategic advisory role in 2026. By expanding its credit capacity and arranging for legal leadership continuity through a consulting agreement, the...

In December 2025, Victory Capital Holdings, Inc. reported that it had added three new UCITS funds via its partnership with Amundi, bringing its UCITS lineup to 22 and expanding its international asset management footprint through RS Investments’ Global Equity and US Value teams. This expansion deepens Victory Capital’s access to European and cross-border investors while showcasing how its franchise model and Amundi alliance are being used to scale specialized equity strategies...

In December 2025, Savara Inc. was added to the S&P Biotechnology Select Industry Index after the European Patent Office signaled its intention to grant patent protection for the liquid formulation of MOLBREEVI, an inhaled GM-CSF therapy for autoimmune PAP. This combination of index inclusion and advancing intellectual property around a Fast Track- and Breakthrough Therapy-designated rare-disease candidate highlights growing recognition of Savara’s specialist respiratory focus. We’ll...

Middleby (MIDD) is back in focus after fresh reports underscored a tougher backdrop, from flat organic revenue growth to slipping operating efficiency and thinner returns on capital, all feeding into a more cautious Street narrative. See our latest analysis for Middleby. Despite the operational worries, investors have recently warmed back up to Middleby, with a roughly 28 percent 1 month share price return helping lift year to date gains and backing up a solid multi year total shareholder...

Earlier in December 2025, the FDA authorized six on! Plus nicotine pouch products from Altria-owned Helix Innovations, while Altria also announced CEO Billy Gifford’s planned May 2026 retirement, with Salvatore Mancuso set to succeed him and Heather Newman becoming CFO. This combination of regulatory progress in smoke-free products and an internally sourced leadership transition highlights Altria’s effort to reposition its portfolio beyond traditional cigarettes. We’ll now look at how FDA...

Preferred Bank recently announced that its Board of Directors approved an increase in the annual cash dividend to US$3.20 per share from US$3.00, a 6.7% uplift, payable on January 20, 2026 to shareholders of record as of January 6, 2026. This higher dividend underscores management’s confidence in Preferred Bank’s financial position and its ongoing emphasis on returning cash directly to shareholders. We’ll now examine how the increased annual dividend influences Preferred Bank’s investment...